Life Biosciences Funding. TMO. All rights reserved. Life Biosciences stock price, funding rounds, valuation and financials. Stock analysis for NutraLife Biosciences Inc (NLBS:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Copyright © 1999 – 2019 GoDaddy Operating Company, LLC. © 2020 Life Biosciences Inc. All rights reserved. Find the latest Precision BioSciences, Inc. (DTIL) stock quote, history, news and other vital information to help you with your stock trading and investing. LIFE BIOSCIENCES® is a registered trademark and all logos are trademarks owned by Life Biosciences Inc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utraFuels, Inc. announces its name change to NutraLife BioSciences, Inc. and a new stock trading symbol, NLBS; NutraLife BioSciences is a fully reporting company with a class of securities registered with the SEC; Quarter-to-quarter and year-over-year growth reflects substantial earnings increases: 2016 earnings: $252,000; 2017 earnings: $1.8M [])), +((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+[])+(+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])-[])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![]))/+((!+[]+(!![])+!![]+!![]+!![]+!![]+[])+(+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])-[])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!!

This means our therapies each have the potential to address multiple age-related diseases that impact longevity far upstream from conventional medicine. … SAN DIEGO and TORONTO, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, and the Aptose management team will participate at the … Developer of medical biotechnology intended to overcome age-related decline. OTTAWA, ON, Sept. 10, 2020 /CNW/ - Élisabeth Brière, Member of Parliament for Sherbrooke, on behalf of the Honourable Seamus O'Regan, Canada's Minister of Natural Resources, invites media representatives to attend the E2Metrix press conference where she will announce funding for a clean technology project in the mining sector.